Augustine J. Lawlor's Insider Trades & SAST Disclosures
Augustine J. Lawlor's most recent trade in Leap Therapeutics Inc was a trade of 22,500 Restricted Stock Units done . Disclosure was reported to the exchange on March 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Augustine J. Lawlor.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 22,500 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 22,500 | 27,586 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.32 per share. | 28 Mar 2025 | 7,797 | 19,789 (0%) | 0% | 0.3 | 2,469 | Common Stock |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | 13 Nov 2024 | 2,136 | 678,456 (2%) | 0% | 2.8 | 6,024 | Common Stock | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | 13 Nov 2024 | 2,136 | 0 | - | - | Warrant (Right to Buy) | ||
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | J. Augustine Lawlor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Lawlor J. Augustine | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 5,000 | 5,086 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 225,000 | 225,000 | - | - | Restricted Stock Units | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 5,839 | 24,573 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 5,542 | 18,734 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 4,761 | 13,192 (0%) | 0% | 0 | Common Stock | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Feb 2021 | 571,428 | 0 | - | - | Warrant (Right to Buy) | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Feb 2021 | 11,544 | 11,544 | - | - | Warrant (Right to Buy) | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 3,417 | 8,431 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 5,014 | 5,014 (0%) | 0% | 0 | Common Stock | |
| Leap Therapeutics Inc | Augustine J. Lawlor | Chief Operating Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 3,673 | 24,215 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Augustine J. Lawlor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges